Abstract
C17H12N2O3, monoclinic, P21/c (no. 14), a = 7.2641(5) Å, b = 12.3968(6) Å, c = 16.1786(13) Å, β = 108.200(6)°, V = 1384.02(16) Å3, Z = 4, Rgt(F) = 0.0905, wRref(F2) = 0.1928, T = 293(2) K.
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Orange plate |
Size: | 0.60 × 0.27 × 0.03 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 1.0 cm−1 |
Diffractometer, scan mode: | STOE IPDS 2, ω-scans |
2θmax, completeness: | 55.2°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 8884, 3177, 0.143 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 1601 |
N(param)refined: | 199 |
Programs: | Stoe programs [10], SHELX [11], Platon [12, 13] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
C1 | 0.8113(4) | 0.3274(2) | 0.57499(17) | 0.0462(7) |
C2 | 0.8423(4) | 0.2748(2) | 0.65536(18) | 0.0509(7) |
C3 | 0.8641(5) | 0.1639(2) | 0.6624(2) | 0.0587(8) |
H3 | 0.8846 | 0.1307 | 0.7161 | 0.070* |
C4 | 0.8556(5) | 0.1028(2) | 0.5910(2) | 0.0611(8) |
H4 | 0.8695 | 0.0283 | 0.5960 | 0.073* |
C5 | 0.8261(5) | 0.1523(2) | 0.51121(19) | 0.0533(7) |
C6 | 0.8030(4) | 0.2627(2) | 0.50383(19) | 0.0516(7) |
H6 | 0.7812 | 0.2947 | 0.4496 | 0.062* |
C7 | 0.7847(6) | 0.4444(2) | 0.5587(2) | 0.0713(10) |
H7 | 0.7929 | 0.4883 | 0.6064 | 0.086* |
C8 | 0.7328(5) | 0.5982(2) | 0.4770(2) | 0.0560(7) |
C9 | 0.6874(4) | 0.6331(2) | 0.3892(2) | 0.0505(7) |
C10 | 0.6638(5) | 0.5607(3) | 0.3195(2) | 0.0645(9) |
H10 | 0.6797 | 0.4871 | 0.3305 | 0.077* |
C11 | 0.6181(6) | 0.5975(3) | 0.2363(2) | 0.0784(10) |
H11 | 0.6015 | 0.5489 | 0.1908 | 0.094* |
C12 | 0.5959(6) | 0.7083(3) | 0.2186(3) | 0.0858(12) |
H12 | 0.5636 | 0.7326 | 0.1615 | 0.103* |
C13 | 0.6210(5) | 0.7801(3) | 0.2842(3) | 0.0789(11) |
H13 | 0.6085 | 0.8534 | 0.2716 | 0.095* |
C14 | 0.6659(5) | 0.7457(2) | 0.3714(2) | 0.0595(8) |
C15 | 0.6900(5) | 0.8186(2) | 0.4408(3) | 0.0697(9) |
H15 | 0.6761 | 0.8922 | 0.4294 | 0.084* |
C16 | 0.7331(6) | 0.7832(2) | 0.5236(3) | 0.0745(10) |
H16 | 0.7481 | 0.8325 | 0.5686 | 0.089* |
C17 | 0.7554(6) | 0.6727(2) | 0.5422(2) | 0.0715(10) |
H17 | 0.7860 | 0.6495 | 0.5995 | 0.086* |
N1 | 0.8553(4) | 0.3349(2) | 0.73374(17) | 0.0608(7) |
N2 | 0.7547(5) | 0.48626(19) | 0.49209(18) | 0.0784(10) |
O1 | 0.8209(4) | 0.08877(15) | 0.44248(14) | 0.0751(7) |
H1 | 0.8025 | 0.1262 | 0.3989 | 0.113* |
O2 | 0.8685(4) | 0.2842(2) | 0.80081(15) | 0.0903(9) |
O3 | 0.8545(5) | 0.4327(2) | 0.73294(17) | 0.0969(9) |
Source of material
(E)-3-((naphthalen-1-ylimino)methyl)-4-nitrophenol was prepared by refluxing a mixture of a solution containing 5-hydroxy-2-nitro-benzaldehyde (8.4 mg, 0.05 mmol) in ethanol (20 mL) and a solution containing 1-naphthylamine (7.2 mg, 0.05 mmol) in ethanol (20 mL). The reaction mixture was stirred for 5 h under reflux. Single crystals of the title compound were obtained by slow evaporation of an ethanolic solution (Yield 70%; m.p. 458–459 K).
Experimental details
For least-squares refinement of the crystal structure all H atoms were placed in calculated positions using a suitable riding model, with C—H distances of 0.93 Å and O—H distances of 0.82 Å, Uiso(H) = 1.2Ueq(C) and 1.5Ueq(O).
Discussion
Schiff bases are an important class of organic molecules which contain imine and azomethine groups. Schiff bases were first discovered by Hugo Schiff in 1864 [1]. Some Schiff bases show biological activities such as anti-inflammatory, antimicrobial, anticonvulsant, anticancer, analgesic etc. [2; 3; 4]. And also, their metal complexes often exhibit antibacterial, antiviral, fungicidal or antitubarculoral activity [5, 6].
In the title compound, C17H12N2O3, the naphthalen and phenyl ring groups are planar with an r.m.s. deviation of 0.010(4) Å for atom C12 in naphthalen group and −0.005(3) Å for atom C5 in the phenyl group, respectively. However the whole molecule is also nearly planar with the dihedral angle is 5.79(8)° between the related ring systems. The torsion angle around the C1—C7—N2—C8 is −178.8(3)° shows that the molecular structure has E configuration. The C = N bond length is 1.154(4) Å, slightly shorther than in related structures [7, 8].
The molecular structure contains O—H⋯O type intermolecular and C—H⋯O and C—H⋯N type intramolecular H bonds. O1—H1⋯O2 (with symmetry code: x, −y + 1/2, + z−1/2) creates an infinite chain along the c-axis and generates a C(8) motif [9]. S(6) and S(5) loops are created by the intramolecular H bonds C7—H7⋯O3 and C10—H10⋯N2, respectively [9]. There is also π-π stacking which contributes to stabilization between the ring centroids of Cg(1)—Cg(2) [distance between ring centroids is 3.695(2) Å with symmetry code: 1−x, 1−y, 1−z where Cg(1) belongs to the C1—C6 ring and Cg(2) to C8/C9/C14/C15/C16/C17].
Acknowledgements:
The single crystal X-ray data were collected at the Faculty of Arts and Sciences, Ondokuz Mayıs University, Turkey, using a Stoe IPDS II diffractometer and crystallographic data were deposited under CCDC number 1484947.
References
1 Schiff, H.: Mitteilungen aus dem Universitätslaboratorium in Pisa: Eine neue Reihe organischer Basen. Justus Liebigs Ann. Chem. 131 (1864) 118–119.10.1002/jlac.18641310113Search in Google Scholar
2 Kajal, A.; Bala, S.; Kamboj, S.; Sharma, N.; Saini, V.: Schiff Bases: A versatile pharmacophore. J. Catal. Volume (2013), Article ID 893512, 14 pages.10.1155/2013/893512Search in Google Scholar
3 Sondhi, M. S.; Singh, N.; Kumar, A.; Lozachc O.; Meijerc, L.: Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases. Bioorg. Med. Chem. 14 (2006) 3758–3765.10.1016/j.bmc.2006.01.054Search in Google Scholar PubMed
4 Venkatesh, P.: Synthesis, Characterization and antimicrobial activity of various Schiff base complexes of Zn(II) and Cu(II) ions. AJPHS 1 (2011) 8–11.Search in Google Scholar
5 Chohan, Z. H.; Praveen, M.; Ghaffer, A.: Structural and biological behaviour of Co(II), Cu(II) and Ni(II) metal complexes of some amino acid derived Schiff-Base ligands. Met-Based Drugs 4 (1997) 267–272.10.1155/MBD.1997.267Search in Google Scholar PubMed PubMed Central
6 Jian Lv, J.; Liu, T.; Cai, S.; Wang, X.; Liu, L.; Wang, Y.: Synthesis, structure and biological activity of cobalt(II) and copper(II) complexes of valine-derived schiff bases. J. Inorg. Biochem. 100 (2006) 1888–1896.10.1016/j.jinorgbio.2006.07.014Search in Google Scholar PubMed
7 Tahir, M. N.; Anwar-ul-Haq, M.; Shad, H. A.: Crystal structure of 1-{(E)-[(3,4-dichlorophenyl)imino]methyl}naphthalen-2-ol. Acta Crystallogr. E71 (2015) o696.10.1107/S2056989015015959Search in Google Scholar PubMed PubMed Central
8 Abu-Dief, A. M.; Abdelbaky, M. S. M.; Garcia-Granda, S.: Crystal structure of (E)-1-{[(3,5-dimethylphenyl)imino]methyl}naphthalen-2-ol. Acta Crystallogr. E71 (2015) o496–497.10.1107/S2056989015011548Search in Google Scholar PubMed PubMed Central
9 Bernstein, J.; Davies, R. E.; Shimoni, L.; Chang, N.-L.: Patterns in hydrogen bonding: Functionality and graph set analysis in crystals, Angew. Chem. Int. Ed. Engl. 34 (1995) 1555–1573.10.1002/anie.199515551Search in Google Scholar
10 Stoe&Cie X-AREA (Version 1.18) and X-RED32 (Version1.04). Stoe&Cie, Darmstadt, Germany (2002).Search in Google Scholar
11 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
12 Farrugia, L. J.: ORTEP-3 for Windows. J. Appl. Cryst. 30 (1997) 565.10.1107/S0021889897003117Search in Google Scholar
13 Farrugia, L. J.: WinGX suite for small-molecule single-crystal crystallography. J. Appl. Cryst. 32 (1999) 837–838.10.1107/S0021889899006020Search in Google Scholar
©2016 Hakan Bülbül et al., published by De Gruyter.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.